Nigeria Seeks Investment in Radiopharmaceutical Therapy for Cancer Patients

LAGOS, NIGERIA — Nigeria’s Minister of State for Health and Social Welfare, Dr. Iziaq Salako, has called for increased domestic investment in Nigeria radiopharmaceutical cancer treatment to expand access to advanced oncology care across the country.
Speaking at the International Symposium on Radiopharmaceutical Therapy in Lagos, Salako emphasized that developing local clinical capacity is crucial to improving patient outcomes. The minister was represented by Dr. David Oladele, Deputy Director of Research at the Nigerian Institute of Medical Research (NIMR) in Yaba.
International healthcare leaders endorsed the call to strengthen nuclear medicine infrastructure across West Africa. Masha Maharaj, President-elect of the World Association of Radiopharmaceutical and Molecular Therapy (WARMTH) and Scientific Chair of the symposium, highlighted that international collaboration, education, and research are essential to advancing nuclear medicine globally.
Savvas Frangos, a nuclear physician from Cyprus and President of the World Federation of Nuclear Medicine, praised regional efforts to build specialized oncology infrastructure. Emeka Eze, Medical Director at Loveworld and Chairman of the 2026 symposium, noted that expanding Nigeria radiopharmaceutical cancer treatment through precision oncology offers targeted care with potentially fewer side effects.
Why it matters: Building radiopharmaceutical capacity directly in Nigeria brings advanced precision oncology closer to home, reducing reliance on costly international travel for complex cancer treatments.
Source: Premium Times, 29 August 2026.


